Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations
- PMID: 16885722
- DOI: 10.1097/00007691-200608000-00009
Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations
Abstract
Estimating the time of last cannabis use is important in assessing possible impairment of drivers involved in accidents, in verifying accuracy of court testimony and in the future, helpful in therapeutic monitoring of cannabis agonists. In 1992, Huestis et al developed model 1, based on plasma Delta-tetrahydrocannabinol (THC) concentrations, and model 2, on plasma 11-nor-9-carboxy-Delta(9)-tetrahydrocannbinol/THC ratios, that predicted 95% confidence intervals for time of last cannabis use. These models seemed to be valuable when applied to the small amount of data from published studies of oral ingestion, a route of administration more popular with the advent of cannabis therapies. A study was designed to further validate the models after oral ingestion of THC, and to determine whether they could predict last usage after multiple oral doses. Eighteen subjects in IRB-approved studies participated after providing informed consent. Each of 12 subjects in one group received a single 10 mg oral dose of dronabinol (synthetic THC). In another protocol, 6 subjects received 4 different oral daily doses, divided into thirds and administered with meals for 5 consecutive days. There was a 10-day washout period between each dosing regimen. Daily doses were 0.39, 0.47, and 14.8 mg THC in hemp oil and 7.5 mg dronabinol. Blood specimens were collected throughout the study and analyzed for plasma THC and 11-nor-9-carboxy-Delta(9)-tetrahydrocannbinol by gas chromatography/mass spectrometry with limits of quantification (LOQs) of 0.5 and 1.0 ng/mL, respectively. Actual times between ingestion of THC and blood collection spanned 0.5 to 16 hours. All plasma specimens with analyte concentrations >LOQ (n=90) were evaluated. Models 1 and 2 correctly predicted time of last THC ingestion for 74.4% and 90.0% of plasma specimens, respectively. 96.7% of predicted times were correct with one overestimate and 2 underestimates using the time interval defined by the lowest and highest 95% confidence limit of both models. These results provide further evidence of the usefulness of the predictive models in estimating the time of last oral THC ingestion after single or multiple doses.
Similar articles
-
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.Ther Drug Monit. 2006 Aug;28(4):545-51. doi: 10.1097/00007691-200608000-00010. Ther Drug Monit. 2006. PMID: 16885723 Clinical Trial.
-
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.J Anal Toxicol. 2005 Jul-Aug;29(5):327-38. doi: 10.1093/jat/29.5.327. J Anal Toxicol. 2005. PMID: 16105257 Clinical Trial.
-
Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.Clin Chem. 2005 Dec;51(12):2289-95. doi: 10.1373/clinchem.2005.056838. Epub 2005 Oct 13. Clin Chem. 2005. PMID: 16223887 Clinical Trial.
-
Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review.Medicina (Kaunas). 2020 Jun 23;56(6):309. doi: 10.3390/medicina56060309. Medicina (Kaunas). 2020. PMID: 32585912 Free PMC article.
-
"Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review.".Drug Alcohol Depend. 2020 Nov 1;216:108177. doi: 10.1016/j.drugalcdep.2020.108177. Epub 2020 Jul 10. Drug Alcohol Depend. 2020. PMID: 32841811
Cited by
-
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?Addiction. 2009 Dec;104(12):2041-8. doi: 10.1111/j.1360-0443.2009.02705.x. Epub 2009 Oct 5. Addiction. 2009. PMID: 19804462 Free PMC article.
-
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.J Anal Toxicol. 2009 Oct;33(8):469-77. doi: 10.1093/jat/33.8.469. J Anal Toxicol. 2009. PMID: 19874654 Free PMC article.
-
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.Clin Chem. 2011 Nov;57(11):1597-606. doi: 10.1373/clinchem.2011.169490. Epub 2011 Aug 29. Clin Chem. 2011. PMID: 21875944 Free PMC article.
-
Population pharmacokinetic modeling of plasma Δ9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration.Br J Clin Pharmacol. 2020 Mar;86(3):611-619. doi: 10.1111/bcp.14170. Epub 2020 Jan 20. Br J Clin Pharmacol. 2020. PMID: 31747464 Free PMC article.
-
Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.J Chromatogr A. 2010 Feb 26;1217(9):1513-21. doi: 10.1016/j.chroma.2009.12.053. Epub 2010 Jan 4. J Chromatogr A. 2010. PMID: 20083251 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources